z-logo
Premium
Mallinckrodt files Chapter 11, will continue customer operations
Author(s) -
Knopf Alison
Publication year - 2020
Publication title -
alcoholism and drug abuse weekly
Language(s) - English
Resource type - Journals
eISSN - 1556-7591
pISSN - 1042-1394
DOI - 10.1002/adaw.32864
Subject(s) - mallinckrodt , buprenorphine , business , methadone , operations management , medicine , opioid , engineering , psychiatry , family medicine , receptor
Facing lawsuits from all the states and others, Mallinckrodt last week filed Chapter 11 to resolve opioid‐related claims, as well as other claims. Its businesses, including operations for opioid use disorder (OUD) medications methadone and buprenorphine, will continue to supply products to patients and customers.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom